- Home
- SANA vs STGW Comparison
SANA vs STGW Comparison
Compare SANA & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SANA | STGW |
|---|---|---|
| Founded | 2018 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SANA | STGW |
|---|---|---|
| Price | $3.15 | $6.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $7.50 | ★ $8.25 |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.24 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,841,216,000.00 |
| Revenue This Year | N/A | $4.67 |
| Revenue Next Year | N/A | $11.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 12.43 |
| 52 Week Low | $1.27 | $4.03 |
| 52 Week High | $6.55 | $7.17 |
Technical Indicators
Market Signals| Indicator | SANA | STGW |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 70.39 |
| Support Level | $2.85 | $4.94 |
| Resistance Level | $3.24 | $7.02 |
| Average True Range (ATR) | 0.26 | 0.32 |
| MACD | -0.08 | 0.18 |
| Stochastic Oscillator | 6.42 | 86.23 |
Price Performance
Historical ComparisonAbout SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.